antimicrobial cyclic peptides peptide - LL-37 peptide are part of the innate immune response found among all classes of life Antimicrobial Cyclic Peptides: A Promising Frontier in Combating Pathogenic Infections

Daptomycin The escalating threat of antibiotic resistance has spurred a critical need for novel therapeutic strategies. In this landscape, antimicrobial cyclic peptides are emerging as a powerful class of molecules with significant potential to address a wide spectrum of pathogenic bacterial infections and other microbial challenges. These peptides, characterized by their unique cyclic structure, offer distinct advantages over traditional linear antibiotics, including enhanced stability and potent antimicrobial activities作者：P Baindara·2024·被引用次数：7—Antimicrobial peptides (AMPs) are considered a promising alternative to conventional antibiotics to fight against the rapid evolution of ....

Research into antimicrobial cyclic peptides has accelerated, driven by their inherent properties and their role as a vital part of the innate immune response found among all classes of life. These peptides are not new; they represent ancient defense molecules widespread in all life forms.Cyclization of Two Antimicrobial Peptides Improves Their Activity The cyclic nature of these molecules is key to their efficacy. Cyclization of peptides can confer several advantages, including enhanced stability to proteolysis, decreased toxicity and increased bactericidal efficacy. This structural feature contributes to their increased resistance to degradation by enzymes, prolonging their therapeutic lifespan and improving their effectiveness.

The diversity and complexity of antimicrobial cyclic peptides are vast. They are often produced as secondary metabolites composed of up to 50 amino acid residues, with some forming intricate and highly effective antimicrobial cyclic peptidomimetics. Their mechanisms of action are varied, but many exhibit membrane-active cyclic amphiphilic peptides properties. These peptides can interact with and disrupt the cell membranes of microbes, a mechanism distinct from many conventional antibiotics, which can make it harder for bacteria to develop resistance.Cyclic peptides yield promising antimicrobial results For instance, cyclic bactenecin kills cells in a completely different way compared to other antimicrobial peptides, highlighting the diverse strategies employed by these molecules2024年6月11日—Experts at King's College London have created a new method to developcyclic peptides that could pioneer new antibioticsto combat AMR..

The therapeutic applications of antimicrobial cyclic peptides are expandingCyclic peptides discovery to develop new antibiotics to fight .... They are being investigated for their utility in clinical treatment cases of pathogenic bacterial infections, wound healing, and even in combating specific challenging pathogens. For example, studies have shown that antimicrobial cyclic peptides effectively inhibit multiple forms of Borrelia, a genus of bacteria responsible for Lyme disease. The potential of these peptides extends to tackling multidrug-resistant pathogens, with some research exploring the combination of amphiphilic cyclic peptide structures with classical antibiotics to enhance treatment efficacy against multidrug-resistant pathogensStructure and antibacterial activities of new cyclic peptide ....

Furthermore, the field is actively exploring the current strategies for synthesizing cyclic antimicrobial peptides.Current synthetic chemistry towards cyclic antimicrobial ... Advances in synthetic chemistry are enabling the creation of novel cyclic peptides with tailored properties. This includes the development of second generation D,L-α-cyclic peptides and antimicrobial cyclic pseudopeptides, which can offer improved potency and selectivity.作者：Z Pei·2025·被引用次数：5—The cyclic peptide C-LR18 hashigher antibacterial activity and stabilityand a longer half-life than LR18 in rats in vitro and in vivo. The goal is to design cyclic peptides that could pioneer new antibiotics to combat antimicrobial resistance (AMR). This drive is fueled by the recognition that cyclic peptides are considered as a new force against antibiotic resistance.

The inherent stability to proteolysis and the potential for reduced toxicity make cyclic antimicrobial peptides (CAMPs) particularly attractive for therapeutic development. Their enhanced efficacy is often linked to their structural features, such as an amphipathic structure that facilitates interaction with microbial membranes.Structure and antibacterial activities of new cyclic peptide ... Some cyclic peptides have demonstrated higher antibacterial activity and stability and longer half-lives in preclinical models, indicating their promise for in vivo applications.

The exploration of antimicrobial cyclic peptides is not limited to terrestrial sources. Marine cyclic peptides are also a rich source of compounds with significant antimicrobial and antifungal activities, showcasing the broad spectrum of these molecules found in nature作者：EHM Mohammed·2022·被引用次数：42—Amongpeptides, 5a and 6a demonstrated the highestantimicrobialactivity. In combination with 11 commercially availableantibiotics, 5a and 6a ....

In summary, antimicrobial cyclic peptides represent a vital area of research and development in the fight against infectious diseases. Their unique structure, diverse mechanisms of action, and inherent advantages in stability and efficacy position them as a promising alternative and complement to existing antibiotics. Continued research into their synthesis, biological activity, and therapeutic applications holds the key to unlocking their full potential in safeguarding public health against the growing threat of microbial resistance.